The study included a 6-week conversion from CL+E or CLE to IPX066 , followed by two 2-week , double-blind crossover treatment periods in randomized order , one on IPX066 ( and placebo CL+E ) , the other on CL+E ( and placebo IPX066 ) , separated by 1-week open-label IPX066 treatment .